Atlas Trials

Effect of Consumption of Pep19 on Quality of Life

Clinical trial NCT06359327 · COMPLETED

Trial details

NCT number
NCT06359327
Sponsor
Proteimax Biotechnology Israel LTD
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Quality of LifeObesitySleep Quality
Start date
2024-05-28
Primary completion
2024-07-28
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.